XBIO vs. XOM
XBIO (Xenetic Biosciences, Inc.) and XOM (Exxon Mobil Corporation) are both stocks. XBIO operates in Biotechnology (Healthcare), while XOM operates in Oil & Gas Integrated (Energy). Over the past 10 years, XBIO returned -42.70%/yr vs 10.14%/yr for XOM. At a 0.05 correlation, their price movements are largely independent.
Performance
XBIO vs. XOM - Performance Comparison
Loading charts...
Returns By Period
In the year-to-date period, XBIO achieves a 58.06% return, which is significantly higher than XOM's 28.05% return. Over the past 10 years, XBIO has underperformed XOM with an annualized return of -42.70%, while XOM has yielded a comparatively higher 10.14% annualized return.
XBIO
- 1D
- 2.69%
- 1M
- 11.00%
- YTD
- 58.06%
- 6M
- 35.04%
- 1Y
- 11.70%
- 3Y*
- 2.82%
- 5Y*
- -31.95%
- 10Y*
- -42.70%
XOM
- 1D
- -0.32%
- 1M
- -1.17%
- YTD
- 28.05%
- 6M
- 31.55%
- 1Y
- 53.36%
- 3Y*
- 16.87%
- 5Y*
- 24.35%
- 10Y*
- 10.14%
XBIO vs. XOM - Yearly Performance Comparison
| 2026 (YTD) | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | |
|---|---|---|---|---|---|---|---|---|---|---|
XBIO Xenetic Biosciences, Inc. | 58.06% | -45.61% | 15.65% | 21.01% | -77.90% | -36.76% | 41.67% | -92.68% | -14.54% | -55.37% |
XOM Exxon Mobil Corporation | 28.05% | 15.98% | 11.26% | -6.26% | 87.41% | 57.58% | -36.21% | 7.23% | -15.09% | -3.81% |
Correlation
The correlation between XBIO and XOM is -0.02, meaning there is essentially no relationship between their price movements. Each responds to its own set of market drivers, making them strong candidates for combining in a diversified portfolio.
| Correlation | |
|---|---|
Correlation (1Y) Calculated over the trailing 1-year period | -0.02 |
Correlation (3Y) Calculated over the trailing 3-year period | 0.01 |
Correlation (5Y) Calculated over the trailing 5-year period | 0.04 |
Correlation (10Y) Calculated over the trailing 10-year period | 0.07 |
Correlation (All Time) Calculated using the full available price history since Jul 1, 2014 | 0.05 |
Fundamentals
XBIO:
$7.86M
XOM:
$635.98B
XBIO:
-$1.17
XOM:
$5.93
XBIO:
2.06
XOM:
1.99
XBIO:
1.13
XOM:
2.50
XBIO:
$3.19M
XOM:
$326.01B
XBIO:
$2.38M
XOM:
$83.11B
XBIO:
-$2.37M
XOM:
$60.44B
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Return for Risk
XBIO vs. XOM — Risk / Return Rank
XBIO
XOM
XBIO vs. XOM - Risk-Adjusted Trends Comparison
This table presents a comparison of risk-adjusted performance metrics for Xenetic Biosciences, Inc. (XBIO) and Exxon Mobil Corporation (XOM). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
| XBIO | XOM | Difference | |
|---|---|---|---|
| Sharpe ratioReturn per unit of total volatility | -2.13 | ||
| Sortino ratioReturn per unit of downside risk | -1.04 | ||
| Omega ratioGain probability vs. loss probability | 1.21 | 1.36 | -0.14 |
| Calmar ratioReturn relative to maximum drawdown | 0.15 | 3.42 | -3.27 |
| Martin ratioReturn relative to average drawdown | 0.20 | 9.70 | -9.50 |
Data is calculated on a 1-year rolling basis and updated daily. The trend shows the change in the indicator over the past month. | |||
Loading charts...
Sharpe Ratios by Period
| XBIO | XOM | Difference | |
|---|---|---|---|
Sharpe Ratio (1Y)Calculated over the trailing 1-year period | 0.07 | 2.19 | -2.13 |
Sharpe Ratio (5Y)Calculated over the trailing 5-year period | -0.30 | 0.92 | -1.21 |
Sharpe Ratio (10Y)Calculated over the trailing 10-year period | -0.32 | 0.36 | -0.68 |
Sharpe Ratio (All Time)Calculated using the full available price history | -0.31 | 0.48 | -0.78 |
Drawdowns
XBIO vs. XOM - Drawdown Comparison
The maximum XBIO drawdown since its inception was -99.95%, which is greater than XOM's maximum drawdown of -62.40%. Use the drawdown chart below to compare losses from any high point for XBIO and XOM.
Loading charts...
Drawdown Indicators
| XBIO | XOM | Difference | |
|---|---|---|---|
Max DrawdownLargest peak-to-trough decline | -99.95% | -62.40% | -37.55% |
Max Drawdown (1Y)Largest decline over 1 year | -80.50% | -15.69% | -64.81% |
Max Drawdown (3Y)Largest decline over 3 years | -80.50% | -18.92% | -61.58% |
Max Drawdown (5Y)Largest decline over 5 years | -96.19% | -20.51% | -75.68% |
Max Drawdown (10Y)Largest decline over 10 years | -99.78% | -61.34% | -38.44% |
Current DrawdownCurrent decline from peak | -99.91% | -10.73% | -89.18% |
Average DrawdownAverage peak-to-trough decline | -91.41% | -10.20% | -81.21% |
Ulcer IndexDepth and duration of drawdowns from previous peaks | 59.99% | 5.52% | +54.47% |
Volatility
XBIO vs. XOM - Volatility Comparison
Xenetic Biosciences, Inc. (XBIO) has a higher volatility of 12.44% compared to Exxon Mobil Corporation (XOM) at 10.07%. This indicates that XBIO's price experiences larger fluctuations and is considered to be riskier than XOM based on this measure. The chart below showcases a comparison of their rolling one-month volatility.
Loading charts...
Volatility by Period
| XBIO | XOM | Difference | |
|---|---|---|---|
Volatility (1M)Calculated over the trailing 1-month period | 12.44% | 10.07% | +2.37% |
Volatility (6M)Calculated over the trailing 6-month period | 50.70% | 20.30% | +30.40% |
Volatility (1Y)Calculated over the trailing 1-year period | 168.58% | 24.49% | +144.09% |
Volatility (5Y)Calculated over the trailing 5-year period, annualized | 107.89% | 26.73% | +81.16% |
Volatility (10Y)Calculated over the trailing 10-year period, annualized | 134.10% | 28.18% | +105.92% |
Dividends
XBIO vs. XOM - Dividend Comparison
XBIO has not paid dividends to shareholders, while XOM's dividend yield for the trailing twelve months is around 2.68%.
| Position | TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
XBIO Xenetic Biosciences, Inc. | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
XOM Exxon Mobil Corporation | 2.68% | 3.32% | 3.57% | 3.68% | 3.22% | 5.70% | 8.44% | 4.92% | 4.74% | 3.66% | 3.30% | 3.69% |
Financials
XBIO vs. XOM - Financials Comparison
This section allows you to compare key financial metrics between Xenetic Biosciences, Inc. and Exxon Mobil Corporation. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.
Total Revenue: Total amount of money received from sales and other business activities
XBIO vs. XOM - Profitability Comparison
XBIO - Gross Margin
Gross margin is calculated as gross profit divided by revenue. For the three months ending on Jun 2026, Xenetic Biosciences, Inc. reported a gross profit of 0.00 and revenue of 806.92K. Therefore, the gross margin over that period was 0.0%.
XOM - Gross Margin
Gross margin is calculated as gross profit divided by revenue. For the three months ending on Jun 2026, Exxon Mobil Corporation reported a gross profit of 31.36B and revenue of 83.16B. Therefore, the gross margin over that period was 37.7%.
XBIO - Operating Margin
Operating margin is calculated as operating income divided by revenue. For the three months ending on Jun 2026, Xenetic Biosciences, Inc. reported an operating income of -502.12K and revenue of 806.92K, resulting in an operating margin of -62.2%.
XOM - Operating Margin
Operating margin is calculated as operating income divided by revenue. For the three months ending on Jun 2026, Exxon Mobil Corporation reported an operating income of 5.29B and revenue of 83.16B, resulting in an operating margin of 6.4%.
XBIO - Net Margin
Net margin is calculated as net income divided by revenue. For the three months ending on Jun 2026, Xenetic Biosciences, Inc. reported a net income of -456.38K and revenue of 806.92K, resulting in a net margin of -56.6%.
XOM - Net Margin
Net margin is calculated as net income divided by revenue. For the three months ending on Jun 2026, Exxon Mobil Corporation reported a net income of 4.18B and revenue of 83.16B, resulting in a net margin of 5.0%.
Frequently Asked Questions
XBIO and XOM have a correlation of -0.02, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.
XBIO has higher volatility (12.44%) compared to XOM (10.07%). In terms of maximum drawdown, XBIO dropped -99.95% vs XOM's -62.40%.
XOM currently has the higher Sharpe Ratio (2.19 vs 0.07), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.
Find the right allocation for XBIO and XOM
Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.
Open Portfolio Optimizer